Lead Portfolio Analyst, Portfolio Management (Oncology) @ TESARO, Inc. (Now a Subsidiary of GlaxoSmithKline (GSK))
Sr. Program Manager\Program Leader (Oncology) @ TESARO, Inc. (Now a Subsidiary of GlaxoSmithKline (GSK))
Associate Director, Drug Development Management (Oncology) @ Millennium Pharmaceuticals (Now Takeda Oncology)
Jim Huebner's Education
Suffolk University
Master’s Degree (Ethics & Public Policy)
2012 - 2015
Western Michigan University
Master’s Degree (Biological Sciences)
1992 - 1995
Western Michigan University
Bachelor’s Degree (Biology)
1986 - 1992
Catholic Central High School
High School (College Prep)
1980 - 1984
Western Michigan University
Master's degree (Biological and Biomedical Sciences)
Jim Huebner's Summary
Jim Huebner, based in Boston, MA, US, is currently a Director, Program Management at Dyne Therapeutics, bringing experience from previous roles at Talaris Therapeutics (Ceased independent operations in early 2023), Radius Health Services, Inc. (Acquired by Gurnet Point and Patient Square Capita, Epizyme (Acquired by Ipsen in 2022) and Centrexion Therapeutics Corp.. Jim Huebner holds a 2012 - 2015 Master’s Degree in Ethics & Public Policy @ Suffolk University. Jim Huebner has 1 email on RocketReach.